NEW YORK, NY — For diabetic patients with blocked coronary arteries, angioplasty performed using a second-generation drug-eluting stent (DES) results in survival similar to surgery, an ...

Vienna, Austria - One of the largest studies to date looking at the impact of stent thrombosis and its treatment suggests that once thrombosis occurs, it matters very little whether the culprit was a ...

About one in eight patients who undergo successful PCI with DES will suffer a clinically relevant bleeding event, MI, or stent thrombosis within 2 years, according to an analysis of the ADAPT-DES ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For percutaneous ...

Please provide your email address to receive an email when new articles are posted on . Patients from a real-world registry who received primary PCI with stenting had a 30-day stent thrombosis rate of ...

Although in-stent restenosis (ISR) is not on the radar of operators as much as it once was, the proportion of PCIs performed for it has remained steady over time in the United States, accounting for ...

Please provide your email address to receive an email when new articles are posted on . PCI for in-stent chronic total occlusion had similar success rates and in-hospital complications compared with ...

A new angiographic analysis of the CHAMPION PHOENIX trial examined the incidence and impact of stent thrombosis (ST) in patients undergoing percutaneous coronary intervention (PCI). Results of the ...

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for ...

Demand for coronary stents is currently witnessing robust growth in India, mainly due to FDA approval for new stents and increasing number of PCI procedures in hospitals. The coronary stents market in ...